Plavix plus Heartburn Drugs Boost Patients’ Risk for Cardiac Events

 A Medco Health Solutions study presented Tuesday at the American Heart Association meeting in New Orleans reveals that stent patient taking Sanofi-Aventis/Bristol-Myers Squibb’s blood thinner block buster Plavix or clopidogrel along with certain heartburn drugs such as AstraZeneca PLC's Nexium may face a greater risk of heart attack, stroke and other dangerous events than those who took Plavix alone.

link to article